Cancer API Market Players, Industry Size, Share, Analysis and Forecast 2022 – 2030
The Cancer
API Market is expected to reach USD 1,48,545.23 Million
by 2030 at 7.10% CAGR during the forecast period 2022-2030, reveals Market Research Future
(MRFR) in a minutely analyzed research report. Various factors are influencing
the growth of the global cancer API market. Surging demand for small molecule
drugs is one of the preliminary factors boosting the growth of the market. The
small molecule API market is undergoing a period of rapid change. Small
molecules are predominating the pharmaceutical industry and account for nearly
80% of the pharmaceutical sales, indicating their relevance in the future of
pharmaceuticals. Moreover, small molecules have made significant development in
the field of cancer treatment. Moreover, a growing trend of outsourcing has
been witnessed in the manufacture of APIs which is expected to contribute to
the market growth positively. The growth of the pharmaceutical industry in the
developing countries is expected to provide an impetus to the growth of the
cancer API market. The pharmaceutical industry in the developing nations as a
whole is moving on a consolidation path which coupled with the growing number
of mergers and acquisitions has proven to be beneficial for the growth of the
cancer API market. Needless to say, towering cases of oncology diseases have
been the major driving factor behind the growth of the global cancer API
market. The market is also expected to benefit from improving the reimbursement
landscape. On the contrary, the growth of the market might be hindered by
austerity measures in Europe. Ever since the economic downfall in Europe,
Germany passed an act for restructuring the pharmaceutical market in statutory
health insurance in an effort to curb its pharmaceutical spending. German drugs
being the standard point of reference by healthcare providers have created
severe pressure on drug manufacturers to decrease their cost of manufacturing.
Low cure rates, poor efficacy, and side effects of cancer API are other
possible restraints. However, the pharmaceutical industry is advancing rapidly
in the backdrop of patent expiry of several popular drugs which expected to
provide ample of growth opportunities to the global cancer API market
Major Key Players
Clovis Oncology,
Ariad Pharmaceuticals (Takeda), Eli Lilly & Company, AstraZeneca plc,
Gilead
Lifesciences, Bristol-Myers Squibb, F. Hoffman La Roche, Boehringer Ingelheim,
Puma Biotech,
Celgene, Exelixis Inc, Novartis AG, Pfizer Inc, AbbVie Inc., Eisai Ltd, Incyte
Corporation, Bayer AG, TESARO, Inc., are the notable Key
Cancer API Market Players.
.
Segment Analysis
The global cancer Industry has been segmented based
on Tinib, Rafenib, Parib, Lisib, Degib, and Ciclib. By tinib, teh market has
been segmented into Ponatinib, Brigatinib, Ruxolitinib, Erlotinib, Alectinib,
Cobimetinib, Neratinib, Osimertinib, Acalabrutinib, Bosutinib, Crizotinib,
Axitinib, Sunitinib, Ceritinib, Imatinib, Lapatinib, Afatinib, Cabozantinib,
Dasatinib, Ibrutinib, Lenvatinib, and Gefitinib. By Rafenib, the market has
been segmented into Sorafenib, Regorafenib, Vemurafenib, Dabrafenib, and
Enasidenib. By Parib, the market has been segmented into Olaparib, Rucaparib,
and Niraparib. By Lisib, the market has been segmented into Idelalisib and
Copanlisib. By Degib, the market has been segmented into Sonidegib and
Vismodegib. The Ciclib category consists of Palbociclib, Ribociclib, and
Abemaciclib.
Regional Analysis
The cancer API market is proliferating
in the US owing to rise in FDA approvals and high investment in R&D of
cancer APIs which is expected to provide lucrative opportunities for market
expansion. In the meanwhile, Europe and Asia Pacific have not yet approved any
small molecule API molecules which explain the limited growth of the market in
these regions.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment